Author: Russo Partners LLC

Posted Date:

March 26, 2026

Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials

Russo Partners LLC

March 26, 2026